Ketorolac Tromethamine (Toradol, Acular) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 21, 2026
Also sold as: Toradol, Acular, Acuvail, Acular Ls
Some Ketorolac Tromethamine products are in shortage in Canada (3 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 6, 2026.
An anti-inflammatory (NSAID) used for short-term relief of moderate to severe pain.
Products affected
3 / 12
In shortage since
Mar 10, 2017
Est. full return
Nov 6, 2026
Reports on file
57
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
KETOROLAC TROMETHAMINE INJECTION, USP
30MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244947 · since ?, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
KETOROLAC
0.5% · SOLUTION · AA PHARMA INC
DIN 02245821 · since Oct 7, 2025, est. end Nov 6, 2026 · Disruption of the manufacture of the drug.
Active shortage
KETOROLAC
0.5% · SOLUTION · AA PHARMA INC
DIN 02245821 · since Dec 30, 2025, est. end Nov 6, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-KETOROLAC INJECTABLE
30MG · SOLUTION · APOTEX INC
DIN 02243989 · since Mar 10, 2017, no end estimate · DORMANT DIN
Resolved
ACULAR
0.5% · SOLUTION · ABBVIE CORPORATION
DIN 01968300 · ended Jul 10, 2026 · Demand increase for the drug.
Resolved
ACUVAIL
0.45% · SOLUTION · ALLERGAN INC
DIN 02369362 · ended Dec 31, 2021 · Disruption of the manufacture of the drug.
Resolved
ACUVAIL
0.45% · SOLUTION · ABBVIE CORPORATION
DIN 02369362 · ended Jul 15, 2026 · Disruption of the manufacture of the drug.
DIN 02239944 · ended Aug 4, 2025 · Disruption of the manufacture of the drug.
Discontinued
ACULAR LS
0.4% · SOLUTION · ABBVIE CORPORATION
DIN 02248722
Resolved
APO-KETOROLAC
10MG · TABLET · APOTEX INC
DIN 02229080 · ended Mar 20, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 57 reports. All reports are on file with Health Canada.
What's happening
Ketorolac Tromethamine is currently affected by 3 active shortage reports filed with Health Canada by FRESENIUS KABI CANADA LTD, AA PHARMA INC, APOTEX INC.
The reported causes are: disruption of the manufacture of the drug; dormant din. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ketorolac Tromethamine is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).
Recent changes
Jul 21, 2026
Shortage resolved
Jul 16, 2026
Shortage resolved
Jul 16, 2026
Shortage resolved
Jul 16, 2026
Estimated end date pushed back : Jul 27, 2026 → Aug 31, 2026
Jul 15, 2026
Status changed
Common questions
What is Ketorolac Tromethamine used for?
An anti-inflammatory (NSAID) used for short-term relief of moderate to severe pain.
When will Ketorolac Tromethamine be back in stock in Canada?
The latest manufacturer estimate is Nov 6, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Ketorolac Tromethamine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.